Format:
1 Online-Ressource (10 Seiten)
ISSN:
1432-1084
Content:
The purpose of this phase III clinical trial was to compare two different extracellular contrast agents, 1.0 M gadobutrol and 0.5 M gadopentate dimeglumine, for magnetic resonance imaging (MRI) in patients with known or suspected focal renal lesions. Using a multicenter, single-blind, interindividual, randomized study design, both contrast agents were compared in a total of 471 patients regarding their diagnostic accuracy, sensitivity, and specificity to correctly classify focal lesions of the kidney. ...
Note:
Systemvoraussetzungen: PDF-Reader
In:
European radiology, Berlin : Springer, 1991-, Band 18, Heft 11 (2008), Seite 2610-2619, 1432-1084
In:
volume:18
In:
year:2008
In:
number:11
In:
pages:2610-2619
Language:
English
DOI:
10.1007/s00330-008-1054-2
URN:
urn:nbn:de:hebis:30:3-380199
Bookmarklink